Oocyte cryopreservation for fertility preservation in transgender and gender diverse individuals : a SWOT analysis

Article Article scientifique Revue de la littérature Oocyte cryopreservation for fertility preservation in transgender and gender diverse individuals : a SWOT analysis eng 2025-07-28 2025-09 author Barbe Julia Eva 0009-0003-1544-6275 Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. julia.barbe@hug.ch. 854697 author Del Vento Federico Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. 935626 author Moussaoui Dehlia 0000-0002-6987-4916 Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland. 642525 Département de Pédiatrie, Gynécologie et Obstétrique (PETRI) author Crofts Victoria 0000-0002-4488-2012 Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. 646382 author Yaron Michal Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. 668428 Département de Pédiatrie, Gynécologie et Obstétrique (PETRI) author Streuli Marie Isabelle Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. 510982 Département de Pédiatrie, Gynécologie et Obstétrique (PETRI) 3031-3039 10.1007/s10815-025-03579-2 40721906 1058-0468 PMC12559567 https://link.springer.com/article/10.1007/s10815-025-03579-2 Gender affirming hormone therapy may be used to relieve dysphoria among transgender or gender-diverse individuals. However, the long-term effects of these treatments on reproductive health remain uncertain. Before initiating hormone therapy, it is essential that patients are fully informed about the potential impact on their reproductive capabilities. Fertility preservation options, such as oocyte cryopreservation, should be offered to gender diverse individuals who were assigned female at birth. To assist healthcare providers in navigating the complexities of fertility preservation for these patients, we conducted a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis focused of oocyte cryopreservation. This analysis aims to ensure that decisions are both clinically sound and aligned with the patient's reproductive goals. Fertility preservation Oocyte cryopreservation SWOT analysis Transgender and gender diverse individuals Transgender health Dewey 618 58 Département de pédiatrie, gynécologie et obstétrique 223 false 150 L'imagerie cérébrale 184 515 Recherche en infectiologie pédiatrique et en pédiatrie générale 853 Journal of assisted reproduction and genetics 42 9 64b567f1-cf26-46a3-9737-6f08ff1ffc6b Article (Published version) Public oocyte_cryoperservetion_for_fertili.pdf 944302 application/pdf CC BY-4.0 d9a79b80b9fcdecbf97384e4c9ba8abedeb589dfd850350fea2a4932029c1891 openAccess Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Title	Published in	Year	Views	Downloads

Oocyte cryopreservation for fertility preservation in transgender and gender diverse individuals : a SWOT analysis	Journal of assisted reproduction and genetics	2025	5	116
La médecine face au sexe, au genre et aux sexualités	Revue médicale suisse	2023	175	6
La médecine face au sexe, au genre et aux sexualités : de l'histoire au questionnaire TransFert		2022	524	597

Archive ouverte UNIGE

Barbe, Julia Eva

account_balance Affiliation entities

Affiliation entities